Literature DB >> 34361099

Effects of Urolithin A on Mitochondrial Parameters in a Cellular Model of Early Alzheimer Disease.

Carsten Esselun1, Ellen Theyssen1, Gunter P Eckert1.   

Abstract

(1) Background: Ellagitannins are natural products occurring in pomegranate and walnuts. They are hydrolyzed in the gut to release ellagic acid, which is further metabolized by the microflora into urolithins, such as urolithin A (UA). Accumulation of damaged mitochondria is a hallmark of aging and age-related neurodegenerative diseases. In this study, we investigated the neuroprotective activity of the metabolite UA against mitochondrial dysfunction in a cellular model of early Alzheimer disease (AD). (2)
Methods: In the present study we used SH-SY5Y-APP695 cells and its corresponding controls (SH-SY5Ymock) to assess UA's effect on mitochondrial function. Using these cells we investigated mitochondrial respiration (OXPHOS), mitochondrial membrane potential (MMP), adenosine triphosphate (ATP) production, autophagy and levels of reactive oxygen species (ROS) in cells treated with UA. Furthermore, we assessed UA's effect on the expression of genes related to mitochondrial bioenergetics, mitochondrial biogenesis, and autophagy via quantitative real-time PCR (qRT-PCR). (3)
Results: Treatment of SH-SY5Y-APP695 cells suggests changes to autophagy corresponding with qRT-PCR results. However, LC3B-I, LC3B-II, and p62 levels were unchanged. UA (10 µM) reduced MMP, and ATP-levels. Treatment of cells with UA (1 µM) for 24 h did not affect ROS production or levels of Aβ, but significantly increased expression of genes for mitochondrial biogenesis and OXPHOS. Mitochondrial Transcription Factor A (TFAM) expression was specifically increased in SH-SY5Y-APP695. Both cell lines showed unaltered levels of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α), which is commonly associated with mitochondrial biogenesis. Results imply that biogenesis might be facilitated by estrogen-related receptor (ESRR) genes. (4)
Conclusion: Urolithin A shows no effect on autophagy in SH-SY5Y-APP695 cells and its effect on mitochondrial function is limited. Instead, data suggests that UA treatment induces hormetic effects as it induces transcription of several genes related to mitochondrial biogenesis.

Entities:  

Keywords:  Alzheimer’s; ellagitannin; hormesis; metabolite; mitochondria; neurodegeneration; polyphenol; urolithin

Year:  2021        PMID: 34361099     DOI: 10.3390/ijms22158333

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  8 in total

1.  Walnut Oil Reduces Aβ Levels and Increases Neurite Length in a Cellular Model of Early Alzheimer Disease.

Authors:  Carsten Esselun; Fabian Dieter; Nadine Sus; Jan Frank; Gunter P Eckert
Journal:  Nutrients       Date:  2022-04-19       Impact factor: 6.706

Review 2.  Are mitophagy enhancers therapeutic targets for Alzheimer's disease?

Authors:  Jangampalli Adi Pradeepkiran; Ashly Hindle; Sudhir Kshirsagar; P Hemachandra Reddy
Journal:  Biomed Pharmacother       Date:  2022-04-04       Impact factor: 7.419

3.  Identification of ellagic acid and urolithins as natural inhibitors of Aβ25-35-induced neurotoxicity and the mechanism predication using network pharmacology analysis and molecular docking.

Authors:  Hui-Lin Li; Shi-Ying Zhang; Ying-Shan Ren; Jie-Chun Zhou; Ying-Xin Zhou; Wei-Zhong Huang; Xiu-Hong Piao; Zhi-You Yang; Shu-Mei Wang; Yue-Wei Ge
Journal:  Front Nutr       Date:  2022-08-02

Review 4.  Targeted Mitochondrial Epigenetics: A New Direction in Alzheimer's Disease Treatment.

Authors:  Ying Song; Xin-Yi Zhu; Xiao-Min Zhang; He Xiong
Journal:  Int J Mol Sci       Date:  2022-08-26       Impact factor: 6.208

5.  Redox Active α-Lipoic Acid Differentially Improves Mitochondrial Dysfunction in a Cellular Model of Alzheimer and Its Control Cells.

Authors:  Fabian Dieter; Carsten Esselun; Gunter P Eckert
Journal:  Int J Mol Sci       Date:  2022-08-16       Impact factor: 6.208

Review 6.  Neurohormetic phytochemicals in the pathogenesis of neurodegenerative diseases.

Authors:  Adeleh Sahebnasagh; Samira Eghbali; Fatemeh Saghafi; Antoni Sureda; Razieh Avan
Journal:  Immun Ageing       Date:  2022-08-11       Impact factor: 9.701

Review 7.  Role of mitophagy in the neurodegenerative diseases and its pharmacological advances: A review.

Authors:  Qixia Wang; Haoyuan Xue; Yundi Yue; Shiqi Hao; Shu-Hong Huang; Zhaoqiang Zhang
Journal:  Front Mol Neurosci       Date:  2022-10-04       Impact factor: 6.261

Review 8.  Regulation of mitochondrial dysfunction induced cell apoptosis is a potential therapeutic strategy for herbal medicine to treat neurodegenerative diseases.

Authors:  Ruo-Lan Li; Ling-Yu Wang; Hu-Xinyue Duan; Qing Zhang; Xiaohui Guo; Chunjie Wu; Wei Peng
Journal:  Front Pharmacol       Date:  2022-09-22       Impact factor: 5.988

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.